Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary

被引：0
|
作者：
Zoltán Vokó
László Nagyjánosi
Zoltán Kaló
机构：
[1] Eötvös Loránd University,Department of Health Policy & Health Economics, Institute of Economics, Faculty of Social Sciences
[2] Syreon Research Institute,undefined
[3] National Institute for Health Development,undefined
来源：
BMC Public Health | / 12卷
关键词：
Cervical cancer; Human papillomavirus; Vaccine; Cervarix; Hungary; Cost-effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
    Schwarz, Tino F.
    Leo, Oberdan
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : S1 - S10
  • [22] Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women
    Kim, Seung Cheol
    Song, Yong Sang
    Kim, Young-Tae
    Kim, Young Tak
    Ryu, Ki-Sung
    Gunapalaiah, Bhavyashree
    Bi, Dan
    Bock, Hans L.
    Park, Jong-Sup
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (02) : 67 - 75
  • [23] Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania
    Brown, Joelle
    Baisley, Kathy
    Kavishe, Bazil
    Changalucha, John
    Andreasen, Aura
    Mayaud, Philippe
    Gumodoka, Balthazar
    Kapiga, Saidi
    Hayes, Richard
    Watson-Jones, Deborah
    VACCINE, 2014, 32 (05) : 611 - 617
  • [24] Cost-effectiveness of a cervical screening program with human papillomavirus vaccine
    Sopina, Elizaveta
    Ashton, Toni
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) : 290 - 297
  • [25] Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years (vol 25, pg 1197, 2010)
    Kim, Young-Jae
    Kim, Kyung-Tai
    Kim, Jae-Hoon
    Cha, Soon-Do
    Kim, Jae Weon
    Bae, Duk-Soo
    Nam, Joo-Hyun
    Ahn, Woong-Shick
    Choi, Ho-Sun
    Ng, Timothy
    Bi, Dan
    Ok, Jin-Ju
    Descamps, Dominique
    Bock, Hans L.
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (12) : 1831 - 1831
  • [26] Efficacy of Human Papillomavirus Type 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
    Konno, Ryo
    Tamura, Shinobu
    Dobbelaere, Kurt
    Yoshikawa, Hiroyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 847 - 855
  • [27] Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Goldhaber-Fiebert, Jeremy D.
    Stout, Natasha K.
    Salomon, Joshua A.
    Kuntz, Karen M.
    Goldie, Sue J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (05): : 308 - 320
  • [28] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Warner K. Huh
    Erin Williams
    Joice Huang
    Tommy Bramley
    Nick Poulios
    Applied Health Economics and Health Policy, 2015, 13 : 95 - 107
  • [29] Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
    Huh, Warner K.
    Williams, Erin
    Huang, Joice
    Bramley, Tommy
    Poulios, Nick
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (01) : 95 - 107
  • [30] The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Hungary
    Dasbach, E.
    Elbasha, E.
    Insinga, R.
    Nagy, L.
    VALUE IN HEALTH, 2007, 10 (06) : A443 - A443
12345